ANI Pharmaceuticals Inc (ANIP)
61.43
-2.34
(-3.67%)
USD |
NASDAQ |
May 17, 16:00
61.45
+0.02
(+0.03%)
After-Hours: 20:00
ANI Pharmaceuticals Price: 61.43 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 63.86 | 64.51 | 61.28 | 61.43 | 153427.0 |
May 16, 2024 | 64.90 | 64.90 | 63.23 | 63.77 | 132119.0 |
May 15, 2024 | 66.13 | 66.57 | 64.60 | 64.82 | 150915.0 |
May 14, 2024 | 67.50 | 67.97 | 65.43 | 66.03 | 155491.0 |
May 13, 2024 | 67.69 | 69.60 | 67.24 | 67.34 | 140177.0 |
May 10, 2024 | 70.00 | 70.00 | 64.05 | 68.05 | 305694.0 |
May 09, 2024 | 65.94 | 66.70 | 65.50 | 65.88 | 187936.0 |
May 08, 2024 | 66.61 | 67.38 | 65.28 | 65.62 | 161262.0 |
May 07, 2024 | 67.42 | 67.74 | 66.70 | 66.72 | 149589.0 |
May 06, 2024 | 67.39 | 67.90 | 67.03 | 67.36 | 116785.0 |
May 03, 2024 | 67.72 | 67.93 | 66.65 | 67.25 | 108735.0 |
May 02, 2024 | 66.96 | 67.87 | 66.78 | 67.11 | 126678.0 |
May 01, 2024 | 65.91 | 67.30 | 65.68 | 66.52 | 124844.0 |
Apr 30, 2024 | 65.48 | 66.50 | 64.92 | 66.00 | 114040.0 |
Apr 29, 2024 | 65.34 | 65.75 | 65.01 | 65.50 | 75520.00 |
Apr 26, 2024 | 64.83 | 65.60 | 64.68 | 65.36 | 67172.00 |
Apr 25, 2024 | 65.05 | 65.28 | 64.29 | 64.95 | 82931.00 |
Apr 24, 2024 | 66.03 | 66.19 | 65.15 | 65.43 | 83439.00 |
Apr 23, 2024 | 65.90 | 66.90 | 65.51 | 66.14 | 85940.00 |
Apr 22, 2024 | 65.98 | 66.37 | 65.18 | 65.62 | 95322.00 |
Apr 19, 2024 | 64.20 | 65.78 | 64.20 | 65.48 | 207268.0 |
Apr 18, 2024 | 65.30 | 65.98 | 64.43 | 64.58 | 184179.0 |
Apr 17, 2024 | 65.56 | 66.06 | 65.02 | 65.48 | 123206.0 |
Apr 16, 2024 | 66.10 | 66.58 | 65.52 | 65.56 | 99004.00 |
Apr 15, 2024 | 66.83 | 67.30 | 65.65 | 66.30 | 111916.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
23.09
Minimum
Jun 16 2022
85.39
Maximum
Jul 30 2019
44.75
Average
39.35
Median
Feb 01 2022
Price Benchmarks
Ligand Pharmaceuticals Inc | 86.06 |
ADMA Biologics Inc | 9.215 |
Annovis Bio Inc | 8.29 |
United Therapeutics Corp | 274.26 |
Allogene Therapeutics Inc | 2.77 |
Price Related Metrics
PE Ratio | 38.88 |
PS Ratio | 2.247 |
Price to Book Value | 2.849 |
Price to Free Cash Flow | 12.23 |
Earnings Yield | 2.57% |
Market Cap | 1.288B |
Operating PE Ratio | 22.11 |
Normalized PE Ratio | 59.08 |